Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
29 participants
INTERVENTIONAL
2016-11-30
2022-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
IVF Clinical Trial of Two Different Treatment Protocols.
NCT00799929
Control Ovarian Stimulation Timing Test
NCT02397135
Optimal Timing For Embryo Transfer For Low Responder Patients
NCT01040247
Fresh Vs Frozen Surgical Sperm in IVF
NCT03361982
Frozen Blastocyst Transfer Using Conventional Timing Versus Timing by Endometrial Receptivity Analysis
NCT03558399
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Testing group
Timing of trigger at end of ovarian stimulation in an IVF cycle: trigger when 2 follicles reach 18mm, OR 1 follicle reaches 18mm AND 1 follicle is between 16-18mm.
Timing of trigger
Control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Timing of trigger
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have met the requirements of being a patient at CCRM Colorado
* AMA: 39-44 years old And/or
* DOR: AMH \< 1 \& FSH \>10 (age independent)
Exclusion Criteria
* Have not fulfilled requirements for IVF cycle
* Single gene couple or chromosomal rearrangement
* Severe male factor or testicular surgical sperm removal (need sufficient sperm for ICSI)
* One ovary
* Uterine anomalies
* Stage III or IV endometriosis
* Explained recurrent miscarriage
* PCO or PCOS
* Using donor oocyte or gestational carrier
26 Years
44 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fertility Laboratories Of Colorado
OTHER
Colorado Center for Reproductive Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mandy Katz-Jaffe, PhD
Role: STUDY_DIRECTOR
CCRM, FLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Colorado Center for Reproductive Medicine
Lone Tree, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20160397
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.